XJPX3148
Market cap1.13bUSD
Jan 14, Last price
2,761.00JPY
1D
-1.71%
1Q
-11.79%
Jan 2017
10.31%
IPO
384.39%
Name
Create SD Holdings Co Ltd
Chart & Performance
Profile
Create SD Holdings Co., Ltd., through its subsidiaries, engages in drug store, dispensing pharmacy, and nursing care businesses in Japan. The company sells pharmaceuticals, cosmetics, food products, daily goods, etc. It also operates and manages nursing homes and functional training type day service centers, as well as provides cleaning services for shops and administrative assistance work, etc. The company was founded in 1998 and is headquartered in Yokohama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | 2015‑05 | |
Income | ||||||||||
Revenues | 422,330,000 10.86% | 380,963,000 8.62% | 350,744,000 3.62% | |||||||
Cost of revenue | 401,922,000 | 277,975,000 | 255,165,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 20,408,000 | 102,988,000 | 95,579,000 | |||||||
NOPBT Margin | 4.83% | 27.03% | 27.25% | |||||||
Operating Taxes | 5,661,000 | 5,735,000 | 5,442,000 | |||||||
Tax Rate | 27.74% | 5.57% | 5.69% | |||||||
NOPAT | 14,747,000 | 97,253,000 | 90,137,000 | |||||||
Net income | 13,691,000 5.93% | 12,925,000 2.62% | 12,595,000 1.77% | |||||||
Dividends | (3,413,000) | (3,034,000) | (2,908,000) | |||||||
Dividend yield | 1.60% | 1.43% | 1.57% | |||||||
Proceeds from repurchase of equity | 3,250,000 | |||||||||
BB yield | -1.52% | |||||||||
Debt | ||||||||||
Debt current | 6,000 | 15,000 | ||||||||
Long-term debt | 10,000 | |||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 8,712,000 | 8,381,000 | 7,989,000 | |||||||
Net debt | (48,358,000) | (57,420,000) | (58,663,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 21,034,000 | 18,985,000 | 16,101,000 | |||||||
CAPEX | (16,155,000) | (16,305,000) | (7,678,000) | |||||||
Cash from investing activities | (20,207,000) | (20,491,000) | (10,808,000) | |||||||
Cash from financing activities | (140,000) | (3,034,000) | (2,908,000) | |||||||
FCF | 11,974,000 | 83,867,000 | 85,658,000 | |||||||
Balance | ||||||||||
Cash | 38,212,000 | 37,526,000 | 42,067,000 | |||||||
Long term investments | 10,146,000 | 19,900,000 | 16,621,000 | |||||||
Excess cash | 27,241,500 | 38,377,850 | 41,150,800 | |||||||
Stockholders' equity | 130,439,000 | 236,149,000 | 216,173,000 | |||||||
Invested Capital | 111,715,500 | 83,031,150 | 70,106,200 | |||||||
ROIC | 15.14% | 127.01% | 135.09% | |||||||
ROCE | 14.69% | 84.83% | 85.91% | |||||||
EV | ||||||||||
Common stock shares outstanding | 63,502 | 63,219 | 63,219 | |||||||
Price | 3,365.00 0.15% | 3,360.00 14.40% | 2,937.00 -8.79% | |||||||
Market cap | 213,683,567 0.60% | 212,414,237 14.40% | 185,673,008 -8.79% | |||||||
EV | 165,325,567 | 271,276,237 | 233,401,008 | |||||||
EBITDA | 25,403,000 | 107,339,000 | 99,562,000 | |||||||
EV/EBITDA | 6.51 | 2.53 | 2.34 | |||||||
Interest | 92,000 | |||||||||
Interest/NOPBT | 0.10% |